Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01535651 · ClinicalTrials.gov registry record · NA

Using Social Media to Enhance the Impact of the Teen Outreach Program

A NA study, sponsored by Colorado School of Public Health.

Completed
Registry status
NA
Development phase
852
Enrollment target

NCT01535651: Completed NA study, sponsored by Colorado School of Public Health.

NCT01535651 is a NA study that has completed, run by Colorado School of Public Health. The registered enrollment target is 852 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (39% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01535651, a NA study, has completed, sponsored by Colorado School of Public Health.

COMPLETED
Registry status
NA
Development phase
852 participants
Enrollment target

Study Summary

The investigators are exploring the use of short message service (text) messaging by cell phones to enhance the effects of the Teen Outreach Program, an effective teen pregnancy prevention program.

Interventions

  • BEHAVIORAL Teen Outreach Program with Media Enhancement (TOP4ME)

Trial Details

FieldValue
Enrollment Target 852 participants
Start Date 2011-09
Est. Completion 2016-05
Phase NA
Colorado School of Public Health

6 total trials

What the finished NCT01535651 record still lists

NCT01535651 is an interventional study that assigns participants to a tested intervention. The registered 852 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (39% lower).

The record links to 0 conditions, and to 1 intervention - of which Teen Outreach Program with Media Enhancement (TOP4ME) is the first listed.

NCT01535651 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01535651 about?

NCT01535651 is a clinical study titled "Using Social Media to Enhance the Impact of the Teen Outreach Program". The investigators are exploring the use of short message service (text) messaging by cell phones to enhance the effects of the Teen Outreach Program, an effective teen pregnancy prevention program.

What is the current status of trial NCT01535651?

This trial is currently completed. It is a NA study. The enrollment target is 852 participants. The study started on 2011-09. Estimated completion is 2016-05.

What interventions are being tested in trial NCT01535651?

The interventions under investigation include: Teen Outreach Program with Media Enhancement (TOP4ME) (BEHAVIORAL).

Who is sponsoring clinical trial NCT01535651?

This trial is sponsored by Colorado School of Public Health, which has 6 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01535651's enrollment target sits among peer trials

852 131st of 2000 higher than 1,870 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06237452 · 852 participants · Phase 3

    VE303 for Prevention of Recurrent Clostridioides Difficile Infection

  • NCT06422143 · 851 participants · Phase 3

    Pembrolizumab With or Without Maintenance Sacituzumab Tirumotecan (Sac-TMT; MK-2870) in Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) [MK-2870-023]

  • NCT07005102 · 854 participants · Phase 2

    A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer

  • NCT07290491 · 854 participants · Phase 3

    Spiritual Care or Psychotherapy Versus Palliative Care Alone in Patients With Non-Curative Malignancies

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01535651, the US trial registry maintained by the National Library of Medicine. NCT01535651 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.